keyword
https://read.qxmd.com/read/38635084/ineffectiveness-of-hemoadsorption-in-large-animals-with-abdominal-sepsis-a-randomized-controlled-porcine-study
#1
JOURNAL ARTICLE
Vaclav Tegl, Jan Horak, Lukas Nalos, Michala Horakova, Milan Stengl, Martin Matejovic, Jan Benes
OBJECTIVES: The use of hemoadsorption (HA) has become popular in the treatment of vasoplegic states associated with massive cytokine release, including septic shock. However, this approach does not seem to be based on robust evidence, and it does not follow international guidelines. To understand the pathophysiological rationale and timing of HA, we conducted a large animal septic shock experiment. DESIGN: Prospective randomized large-animal peritoneal septic shock experiment...
April 18, 2024: Intensive Care Medicine Experimental
https://read.qxmd.com/read/38633478/systematic-review-with-expert-consensus-on-use-of-extracorporeal-hemoadsorption-in-septic-shock-an-indian-perspective
#2
JOURNAL ARTICLE
Yatin Mehta, Abdul Samad Ansari, Amit Kumar Mandal, Dipanjan Chatterjee, Gauri Shankar Sharma, Prachee Sathe, Purvesh V Umraniya, Rajib Paul, Sachin Gupta, Vinod Singh, Yogendra Pal Singh
BACKGROUND: Septic shock is a severe form of sepsis characterised by deterioration in circulatory and cellular-metabolic parameters. Despite standard therapy, the outcomes are poor. Newer adjuvant therapy, such as CytoSorb® extracorporeal haemoadsorption device, has been investigated and shown promising outcome. However, there is a lack of some guidance to make clinical decisions on the use of CytoSorb® haemoadsorption as an adjuvant therapy in septic shock in Indian Setting...
March 9, 2024: World Journal of Critical Care Medicine
https://read.qxmd.com/read/38633302/does-adjunctive-hemoadsorption-provide-benefit-in-the-management-of-ischemia-reperfusion-syndrome-following-near-drowning-a-case-report
#3
Pedja Kovacevic, Sasa Dragic, Milka Jandric, Danica Momcicevic, Vedrana Malesevic, Tijana Kovacevic, Marijana Matejic-Spasic, Tanja Knezevic, Biljana Zlojutro
Drowning remains a significant global health concern, claiming over 300,000 lives annually, with a disproportionate impact on young individuals in low-and middle-income countries. Conventional mechanical ventilation, while common, falls short in addressing the hypoxemia and hypercapnia often observed in severe near-drowning cases. Veno-venous extracorporeal membrane oxygenation (vvECMO) emerges as a critical intervention for cardiopulmonary failure post-drowning. This case report delves into the pivotal role of ischemia-reperfusion injury (IRI) in a near-drowning-related pathology...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38632635/antithrombotic-drug-removal-with-hemoadsorption-during-off-pump-coronary-artery-bypass-grafting
#4
JOURNAL ARTICLE
Helmut Mair, Stephanie Ulrich, Dow Rosenzweig, Johannes Goeppl, Christopher Jurma, Ferdinand Vogt, Benedikt Baumer, Frank Vogel, Peter Lamm
BACKGROUND: Patients requiring coronary artery bypass grafting (CABG) are often loaded with antithrombotic drugs (AT) and are at an increased risk for perioperative bleeding complications. Active AT removal by a hemoadsorption cartridge integrated in the cardiopulmonary bypass circuit is increasingly used in this setting to reduce bleeding, and herein we describe the extension of this application in patients on AT undergoing off-pump coronary artery bypass (OPCAB). METHODS: Ten patients (80% male; mean age: 67...
April 18, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38582888/effective-apixaban-removal-using-hemoadsorption-during-emergent-open-heart-surgery-a-case-report-and-narrative-literature-review
#5
REVIEW
Vitor Mendes, Jaid Mamode, Jalal Jolou, Mourad Malki, Christoph Ellenberger, Mustafa Cikirikcioglu, Christoph Huber
BACKGROUND: The management of hemostasis in patients medicated with apixaban (Eliquis) undergoing emergency cardiac surgery is exceedingly difficult. The body's natural elimination pathways for apixaban prove ineffective in emergency situations, and the impact of hemodialysis is limited. The application of Cytosorb® may attenuate the concentration of apixaban, thereby facilitating the stabilization of these patients. CASE PRESENTATION: An 84-year-old man treated with apixaban, underwent emergency ascending aorta replacement surgery due to an acute type A aortic dissection...
April 6, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38580477/corrigendum-to-in-vitro-apixaban-removal-by-cytosorb%C3%A2-whole-blood-adsorber-an-experimental-study-journal-of-cardiothoracic-and-vascular-anesthesia-36-6-2024-1636-1644
#6
Henriette Røed-Undlien, Nina Haagenrud Schultz, Asbjørn Lunnan, Inger Marie Husebråten, Birgit Malene Wollmann, Espen Molden, Johannes Lagethon Bjørnstad
No abstract text is available yet for this article.
April 4, 2024: Journal of Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/38535536/supportive-treatment-of-a-dog-with-leishmaniosis-and-severe-glomerulopathy-with-immunoadsorption
#7
Florian Sänger, Michèle Bergmann, Katrin Hartmann, René Dörfelt
A three-year-old, intact female mix-breed dog, weighing 30 kg, was presented due to vomitus and diarrhea. At presentation, the patient had a slightly reduced general condition and moderately enlarged mandibular and popliteal lymph nodes. The initial blood work showed severe azotemia and hypoalbuminemia. In the urinalysis, marked proteinuria with a urine protein/creatinine ratio (UPC) of 4.69 was found. Further workup showed a high leishmania antibody titer. The dog was diagnosed with leishmaniosis and glomerulonephritis...
February 21, 2024: Pathogens
https://read.qxmd.com/read/38514401/impact-of-intraoperative-haemoadsorption-on-outcomes-of-patients-undergoing-aortic-surgery-a-single-centre-prospective-observational-study
#8
JOURNAL ARTICLE
Yatin Mehta, Ajmer Singh, Mandeep Singh, Anil Bhan, Naresh Trehan
TITLE: Impact of Intraoperative Haemoadsorption on Outcomes of Patients undergoing Aortic Surgery: A Single-Centre, Prospective, Observational Study. OBJECTIVES: To investigate the impact of a cytokine haemoadsorption device (CytoSorb®) on inflammatory markers and patients' outcome during aortic root surgery. METHODS: Prospective, observational study including all-comers with quasi-randomisation by strictly alternating inclusion (1:1 basis)...
March 21, 2024: Interdiscip Cardiovasc Thorac Surg
https://read.qxmd.com/read/38512381/severe-rhabdomyolysis-after-exertional-heat-stroke-treated-with-a-hemoadsorber-cytosorb-lesson-for-the-clinical-nephrologist-%C3%A2
#9
JOURNAL ARTICLE
Marijana Mikacic, Tanja Ilic Begovic, Ivan Jerkovic, Marina Maras Batinic, Vedran Kovacic
No abstract text is available yet for this article.
March 21, 2024: Journal of Nephrology
https://read.qxmd.com/read/38494395/cytosorb%C3%A2-in-burn-patients-with-septic-shock-and-acute-kidney-injury-on-continuous-kidney-replacement-therapy-is-associated-with-improved-clinical-outcome-and-survival
#10
JOURNAL ARTICLE
Filippo Mariano, Domenico Greco', Nadia Depetris, Alberto Mella, Alberto Sciarrillo, Maurizio Stella, Maurizio Berardino, Daniela Risso, Roberto Gambino, Luigi Biancone
BACKGROUND: In burn patients, septic shock and acute kidney injury (AKI) with use of continuous renal replacement therapy (CRRT) severely increase morbidity and mortality. Sorbent therapies could be an adjunctive therapy to address the underlying metabolic changes in inflammatory and anti-inflammatory cytokines dysregulated production. METHODS: A retrospectively observational study of 35 severe burn patients admitted to the Burn Center (Turin, Italy, from January 2017 to December 2022), who underwent CRRT for AKI-associated septic shock...
March 1, 2024: Burns
https://read.qxmd.com/read/38488713/preliminary-report-of-extracorporeal-blood-purification-therapy-in-patients-receiving-lvad-cytosorb-or-jafron-ha330
#11
RANDOMIZED CONTROLLED TRIAL
Zhuldyz Nurmykhametova, Timur Lesbekov, Rymbay Kaliyev, Bolat Bekishev, Nilufar Jabayeva, Svetlana Novikova, Linar Faizov, Ivan Vakhrushev, Yuriy Pya
BACKGROUND: Left ventricular assist device (LVAD) candidates are at increased risk of immune dysregulation and infectious complications. To attenuate the elevated proinflammatory cytokine levels and associated adverse clinical outcomes, it has been postulated that extracorporeal blood purification could improve the overall survival rate and morbidity of patients undergoing LVAD implantation. METHODS: We retrospectively reviewed prospectively collected data of 15 patients who underwent LVAD implantation at our center between January 2021 and March 2022...
March 2024: Journal of Extra-corporeal Technology
https://read.qxmd.com/read/38460546/effect-of-hemoadsorption-during-cardiac-surgery-for-s-aureus-endocarditis-a-remove-trial-post-hoc-analysis
#12
JOURNAL ARTICLE
Tulio Caldonazo, Jef Van den Eynde, Torsten Doenst, Hristo Kirov, Marcus Franz, Stefan Hagel, Thomas Lehmann, Mahmoud Diab
OBJECTIVES: Multi-organ failure is one of the leading causes of mortality after cardiac surgery for infective endocarditis (IE). Although the randomized evidence does not support the use of hemoadsorption during cardiac surgery for IE, observational studies suggest a beneficial effect in selected patient groups. S. aureus is the most common pathogen, and its presence is an independent mortality predictor. We aimed to analyze the effect of hemoadsorption in patients with IE caused by S...
March 9, 2024: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/38421742/a-novel-peritoneal-packing-method-for-management-of-hyperkalemia-during-acute-kidney-injury-in-trauma
#13
JOURNAL ARTICLE
Eric M Zimmerman, Ian J Stewart, Todd L Graham, Timothy J Kovacs, Tamaz Guliashvili, Thomas D Golobish, James D Ross
INTRODUCTION: United States Military operations in resource limited areas are increasing. Furthermore, future peer or near-peer conflicts will require caring for larger numbers of casualties with limited resources. In this setting, traditional renal replacement therapy is not feasible and novel methods are required to address severe acute kidney injury in austere environments lacking definitive therapies. Here, we describe experiments designed to determine the efficacy of a novel peritoneal packing material (Potassium Binding Pack-PBP, CytoSorbents INC) for the acute management of severe hyperkalemia...
February 28, 2024: Military Medicine
https://read.qxmd.com/read/38381019/effect-of-cytosorb-on-interleukin-6
#14
JOURNAL ARTICLE
Nicole J B Waalders, Aron Jansen, Peter Pickkers
No abstract text is available yet for this article.
March 1, 2024: Critical Care Medicine
https://read.qxmd.com/read/38337456/a-contemporary-review-of-the-use-of-extracorporeal-cytosorb-%C3%A2-hemoadsorption-therapy-in-patients-with-infective-endocarditis
#15
REVIEW
Anan Gong, Yupei Li, Mei Yang, Shujing Wang, Baihai Su
Infective endocarditis (IE) is a rare but severe disease with high morbidity and mortality. Cardiac surgery plays a major role in the contemporary clinical management of IE patients. During cardiac surgery, cardiopulmonary bypass significantly contributes to an increased risk of organ dysfunction and mortality by inducing an acute inflammatory response, vascular endothelial cell injury, impairment of the coagulation cascade, and ischemia-reperfusion injury. During the past decade, the use of extracorporeal hemoadsorption therapy with the CytoSorb® hemoadsorber (CytoSorbents Europe GmbH, Berlin, Germany) has been proposed as an adjuvant therapy to mediate inflammatory responses in IE patients undergoing cardiac surgery with cardiopulmonary bypass...
January 29, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38262384/in-vitro-removal-of-protein-bound-retention-solutes-by-extracorporeal-blood-purification-procedures
#16
JOURNAL ARTICLE
Claudia Schildböck, Stephan Harm, Jens Hartmann
When the kidneys or liver fail, toxic metabolites accumulate in the patient's blood, causing cardiovascular and neurotoxic complications and increased mortality. Conventional membrane-based extracorporeal blood purification procedures cannot remove these toxins efficiently. The aim of this in-vitro study was to determine whether commercial hemoperfusion adsorbers are suitable for removing protein-bound retention solutes from human plasma and whole blood as well as to compare the removal to conventional hemodialysis...
January 23, 2024: Blood Purification
https://read.qxmd.com/read/38202301/impact-of-cytosorb-hemoadsorption-therapy-on-fluid-balance-in-patients-with-septic-shock
#17
JOURNAL ARTICLE
Klaus Kogelmann, Tobias Hübner, Matthias Drüner, Dominik Jarczak
Recent in vitro studies have investigated the effects of hemoadsorption therapy on endothelial function in sepsis showing a reduction in markers of endothelial dysfunction, but, to this day, there are no clinical studies proving whether this approach could actually positively influence the disturbed vascular barrier function in septic conditions. We retrospectively analyzed data on administered fluid volumes and catecholamines in 124 septic shock patients. We collected catecholamine and volume requirements and calculated the volume balance within different time periods to obtain an assumption on the stability of the vascular barrier...
January 4, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38142295/the-use-of-cytosorb-in-acute-oral-mercuric-chloride-poisoning-at-a-potentially-lethal-dose
#18
JOURNAL ARTICLE
Anna Krakowiak, Beata Janasik, Łukasz Sadowski, Katarzyna Szwabe, Tomasz Wiśniewski, Małgorzata Anna Rak, Waldemar Machała
INTRODUCTION: The study aims to present a case of acute mercuric chloride poisoning treated successfully with continuous renal replacement therapy using the CytoSorb filter. CASE DESCRIPTION: A 21-year-old female patient after a suicide attempt by intentional ingestion of mercuric chloride, was admitted to the hospital with features of multiple organ damage for specific treatment. The performed laboratory tests confirmed high levels of mercury in the blood (1051 μg/L) and urine (22,960 μg/L)...
January 2024: International Journal of Artificial Organs
https://read.qxmd.com/read/38111338/use-of-intraoperative-haemoadsorption-in-patients-undergoing-heart-transplantation-a-proof-of-concept-randomized-trial
#19
JOURNAL ARTICLE
Endre Nemeth, Adam Soltesz, Eniko Kovacs, Zsofia Szakal-Toth, Eszter Tamaska, Hajna Katona, Kristof Racz, Gergely Csikos, Viktor Berzsenyi, Szabolcs Fabry, Zsuzsanna Ulakcsai, Csilla Tamas, Beata Nagy, Marina Varga, Bela Merkely
AIMS: The aim of this trial was to compare the clinical effects of intraoperative haemoadsorption versus standard care in patients undergoing orthotopic heart transplantation (OHT). METHODS AND RESULTS: In a randomized, controlled trial, OHT recipients were randomized to receive intraoperative haemoadsorption or standard care. Outcomes were vasoactive-inotropic score (VIS), frequency of vasoplegic syndrome (VS) in the first 24 h; post-operative change in procalcitonin (PCT) and C-reactive protein (CRP) levels; intraoperative change in mycophenolic acid (MPA) concentration; frequency of post-operative organ dysfunction, major complications, adverse immunological events and length of in-hospital stay and 1-year survival...
December 19, 2023: ESC Heart Failure
https://read.qxmd.com/read/38068250/adjunctive-hemoadsorption-therapy-with-cytosorb-in-patients-with-septic-vasoplegic-shock-a-best-practice-consensus-statement
#20
REVIEW
Steffen Mitzner, Klaus Kogelmann, Can Ince, Zsolt Molnár, Ricard Ferrer, Axel Nierhaus
A dysregulated host response is a common feature in critically ill patients due to both infectious and non-infectious origins that can lead to life-threatening organ dysfunction, which is still the primary cause of death in intensive care units worldwide. In its course, pathologic, unregulated levels of inflammatory mediators are often released into the circulation, a phenomenon also referred to as a "cytokine storm". To date, there are no approved therapies to modulate the excessive immune response and limit hyperinflammation with the goal of preventing related organ failure and death...
November 21, 2023: Journal of Clinical Medicine
keyword
keyword
62511
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.